Safety and Clinical Activity Study of Combination Azacitidine and Avelumab in Patients With Acute Myeloid Leukemia (AML) and Minimal Residual Disease (MRD)
Clinical trial NCT03699384 · WITHDRAWN
Trial details
- NCT number
- NCT03699384
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-03
- Primary completion
- 2019-02-18
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.